Generics - North America, Financial

Filter

Current filters:

North AmericaFinancial

Popular Filters

1 to 25 of 32 results

Teva agrees $27.6 million settlement with US Justice Dept

Teva agrees $27.6 million settlement with US Justice Dept

12-03-2014

US subsidiaries of Israeli generics giant Teva Pharmaceutical Industries have agreed to pay the US government…

ClozapineFinancialGenericsIvaxLegalNeurologicalNorth AmericaTeva Pharmaceutical IndustriesUSA

New data shows FDA’s proposed generic labeling rules would add to health costs

New data shows FDA’s proposed generic labeling rules would add to health costs

06-02-2014

The US Food and Drug Administration’s Proposed Rule on prescription drug labeling would add $4 billion…

FinancialGenericsNorth AmericaRegulationUSA

US national health spending growth remains low for 4th consecutive year

07-01-2014

Overall national health expenditures in the USA grew at an annual rate of 3.7% in 2012, marking the fourth…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalUSA

AstraZeneca wins damages from Apotex

AstraZeneca wins damages from Apotex

04-12-2013

Anglo-Swedish drug major AstraZeneca this morning said it welcomed the US District Court for the Southern…

ApotexAstraZenecaFinancialGastro-intestinalsGenericsNexium I.V.North AmericaPatentsPrilosec

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

22-11-2013

US generics major Actavis (NYSE: ACT) says it has completed the restructuring of its US Specialty Brands…

ActavisFinancialGenericsManagementNorth AmericaUSAWarner Chilcott

Drug swap drives down costs for US Medicare

23-08-2013

Therapeutic drug substitutions have the potential to double or even triple annual cost savings compared…

FinancialGenericsHealthcareNorth AmericaPricing

US FDA jacks up FY 2014 generic drug user fees

13-08-2013

In a Federal Register notice, the US Food and Drug Administration has announced the rate for the Abbreviated…

FinancialGenericsNorth AmericaRegulation

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions

05-08-2013

In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

Highs and lows as Actavis 2nd qtr results meet expectations

25-07-2013

US generics drug major Actavis (NYSE: ACT) reported its net revenue increased 46.8% to $1.99 billion…

ActavisFinancialGenericsNorth AmericaWarner Chilcott

US pharma patent settlements netted $25.5 billion in savings for health system; report

10-07-2013

Generic pharmaceuticals launched prior to patent expiration due to a patent settlement - also called…

FinancialGenericsNorth AmericaPatentsPharmaceutical

$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds

20-06-2013

Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

Tightening health budgets on both sides of the Atlantic leading to crackdowns on patent settlements, says EIU analyst

05-06-2013

Later this month, following an inquiry launched in 2009, the European Commission is expected to impose…

EuropeFinancialGenericsNorth AmericaPatentsPharmaceuticalPoliticsRegulation

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements

14-05-2013

In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Total real per capita spending on medicines in the USA fell 3.5% in 2012

09-05-2013

Total spending on US medicines fell 3.5 percent on a real per capita basis in 2012 and the use of health…

FinancialGenericsHealthcareNorth AmericaPharmaceutical

Adherence to generic cholesterol-lowering drugs linked to fall in total care costs

04-04-2013

People who regularly take statins to reduce high cholesterol will see lower hospitalization rates according…

Cardio-vascularFinancialGenericsMarkets & MarketingNorth America

Par Pharma agrees $45 million settlement over off-label Megace ES promotion

07-03-2013

US generic drugmaker Par Pharmaceutical NYSE: PRX) pleaded guilty in federal court yesterday (March 6)…

FinancialGenericsLegalMarkets & MarketingMegace ESMetabolicsNorth AmericaPar PharmaceuticalPharmaceutical

Mixed views from PhRMA and GPhA on Obama's State of the Union Address

15-02-2013

There were mixed reactions from two sides of the US drug industry - research-based and generic drugmakers…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPolitics

US FDA details Generic Drug User Fee for APIs and finished dosage form facilities for FY2013

18-01-2013

In a federal Register posting, the US Food and Drug Administration has announced the rate for the generic…

FinancialGenericsNorth AmericaProductionRegulation

US physician acquiescence to patient demands for brand-name drugs, slammed in JAMA article

09-01-2013

Prescribing brand-name drugs when generic drugs are available generates unnecessary medical expenditures…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPricing

Medicines for normal aging conditions overtakes costs of treating most chronic diseases; Express Scripts

30-10-2012

In the USA, prescription-drug treatment regimens for conditions that are a normal part of aging are now…

BiotechnologyFinancialGenericsHealthcareNorth AmericaPharmaceutical

Legislative fix would allow FDA to collect GDUFA user fees

20-09-2012

Legislation allowing the US Food and Drug Administration to collect several user fees under the Generic…

FinancialGenericsNorth AmericaRegulation

US Medicare prescription drug premiums to remain steady for third straight year

07-08-2012

Average basic premiums for Medicare prescription drug plans in the USA are projected to remain constant…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPricing

Johnson & Johnson close to settling over Risperdal marketing; SEC probes Teva

06-08-2012

US health care giant Johnson & Johnson (NYSE: JNJ) has reached "an agreement in principle'' with the…

FinancialGenericsInvegaJanssenJohnson & JohnsonLegalMarkets & MarketingNatrecorNorth AmericaPharmaceuticalRisperdalTeva Pharmaceutical Industries

Mylan settles Provigil litigation with Teva

10-06-2012

US generic major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has resolved all…

CephalonFinancialGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaProvigilTeva Pharmaceutical Industries

1 to 25 of 32 results

Back to top